NIH-funded research R01 grant

Understanding rare genetic variations using roundworms

Official title: EDGE CMT: deleterious recessive variation - from experimental data to predictive models

Funded at New York University · NIH-11014384 · Data updated 2026-11-12

This study is looking at how rare genetic changes in roundworms can influence their traits and health, which might help us understand more about genetic diversity and its effects on living things.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University
NIH-funded
Lab location1 site (New York, United States)
Project startFebruary 17, 2023
Project endJanuary 31, 2026
Funding year2025
Award (this year)$333,355
NIH project number5R01HG013015-03
Project IDNIH-11014384 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would be individuals with a family history of genetic disorders associated with recessive alleles.

Less likely to help

Patients with dominant genetic disorders or those without a known genetic component to their condition may not benefit from this research.

What this research studies

This research investigates how rare genetic variations, specifically recessive alleles, affect biological traits using the roundworm Caenorhabditis becei. By creating a system where these rare alleles can be studied more easily, the researchers aim to measure their effects on fitness and gene expression. The study employs advanced experimental techniques to analyze how these genetic factors interact and contribute to overall genetic diversity. This work could provide insights into the underlying mechanisms of genetic variation and its implications for health.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of genetic disorders linked to recessive alleles, potentially leading to better diagnostic and therapeutic strategies.

How similar studies have gone: Similar research approaches have shown promise in understanding genetic variation, but this specific methodology using C. becei is relatively novel.

Where this research is happening

  • New York University
    New York, United States
    Active

Researchers

  • Principal investigator: Rockman, Matthew — New York University
  • Study coordinator: Rockman, Matthew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.